Filter byLast updatedSelectAfterBeforeFrom - ToDateEnd DateCategoryHumanCorporateTopicCOVID-19VaccinesPharmacovigilanceReferralsMedicinesMpoxRegulatory and procedural guidanceAdvanced therapiesAntimicrobial resistanceBiologicalsBiosimilarsBrexitCareersClinical trialsCompassionate useCompliance and inspectionsCorporateData on medicinesEarly accessFeesGeneric and hybrid medicinesGovernanceInnovationMaximum residue limitMedication errorMedicines for use outside the EUMedicine shortagesPaediatricsParallel distributionProcurementProduct informationQuality of medicinesRare diseasesResearch and developmentScientific adviceScientific guidelinesSMEVeterinary limited marketsDiseases areaViral diseasesCancerDiabetesImmune-system diseasesCardiovascular diseasesHIV and AIDSNeurodegenerative diseasesTreatment of human immunodeficiency virus type 1 (HIV-1) infectionResponsible bodyCHMPPRACManagement BoardPDCOCATCMDhCOMPCVMPHMPCPatient safetyYesFiltersResults (55) SpikevaxSort byLast update date (new to old)Last update date (old to new)A-ZZ-AAdapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers25 February 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccinesEMA recommends COVID-19 Vaccine Moderna for authorisation in the EU6 January 2021NewsHumanCOVID-19VaccinesUpdate on assessment of marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine17 December 2020NewsHumanCOVID-19VaccinesEMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine1 December 2020NewsHumanCOVID-19VaccinesEMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain, S.L.16 November 2020NewsHumanCOVID-19MedicinesVaccinesPrevious123456
Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers25 February 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccines
EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU6 January 2021NewsHumanCOVID-19Vaccines
Update on assessment of marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine17 December 2020NewsHumanCOVID-19Vaccines
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine1 December 2020NewsHumanCOVID-19Vaccines
EMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain, S.L.16 November 2020NewsHumanCOVID-19MedicinesVaccines